Now they believe that the newly engineered virus could stamp out tumour growth in metastatic cancer patients. (Image: Getty)But scientists have always faced an overwhelming barrier in the fight against metastatic cancers, being the human immune system. Now, researchers have found a way around that barrier by reengineering the virus delivery system so that the virus is not easily caught by parts of the immune system. The modified virus could eliminate disseminated tumours from some, but not all mice engrafted with human lung cancer cells. He added: "In the clinic, metastatic lung cancer would be the type of cancer most appropriate to test an oncolytic virus against.

Source: Daily Mirror November 25, 2020 19:00 UTC